中国医师杂志
中國醫師雜誌
중국의사잡지
JOURNAL OF CHINESE PHYSICIAN
2010年
7期
891-894
,共4页
胡瑞成%谭双香%戴爱国%蒋永亮
鬍瑞成%譚雙香%戴愛國%蔣永亮
호서성%담쌍향%대애국%장영량
肺疾病,慢性阻塞性/代谢/治疗%白细胞介素10/代谢%白细胞介素13/代谢%治疗结果
肺疾病,慢性阻塞性/代謝/治療%白細胞介素10/代謝%白細胞介素13/代謝%治療結果
폐질병,만성조새성/대사/치료%백세포개소10/대사%백세포개소13/대사%치료결과
Pulmonary disease,Chronic obstructive/ME/TH%Interleukin-10/ME%Interleukin-13/ME%Treatment outcome
目的 探讨COPD急性加重期(AECOPD)患者血浆白介素(IL)-10、IL-13浓度与临床治疗效果之间的关系.方法 36例AECOPD住院治疗患者被纳入研究,用酶联免疫吸附试验检测患者入院时的血浆IL-10和IL-13浓度,对患者的临床表现进行量化评分,根据患者入院时、治疗48h、治疗96 h的临床表现积分结合肺通气功能指标对治疗效果进行评价,分析IL-10、IL-13浓度与治疗效果之间的关系.结果 IL-10浓度与治疗48 h临床表现积分降低值和肺通气功能改善值的相关系数分别为0.85和0.48,与治疗96 h临床表现积分降低值和肺通气功能改善值的相关系数分别为0.64和0.52;IL-13浓度与治疗48 h临床表现积分降低值和肺通气功能改善值的相关系数分别为-0.41和-0.34,与治疗96h临床表现积分降低值的相关系数为-0.36;以上相关系数均具有统计学意义(P<0.05).结论 血浆IL-10浓度与AECOPD治疗效果呈正相关而IL-13浓度与治疗效果呈负相关.
目的 探討COPD急性加重期(AECOPD)患者血漿白介素(IL)-10、IL-13濃度與臨床治療效果之間的關繫.方法 36例AECOPD住院治療患者被納入研究,用酶聯免疫吸附試驗檢測患者入院時的血漿IL-10和IL-13濃度,對患者的臨床錶現進行量化評分,根據患者入院時、治療48h、治療96 h的臨床錶現積分結閤肺通氣功能指標對治療效果進行評價,分析IL-10、IL-13濃度與治療效果之間的關繫.結果 IL-10濃度與治療48 h臨床錶現積分降低值和肺通氣功能改善值的相關繫數分彆為0.85和0.48,與治療96 h臨床錶現積分降低值和肺通氣功能改善值的相關繫數分彆為0.64和0.52;IL-13濃度與治療48 h臨床錶現積分降低值和肺通氣功能改善值的相關繫數分彆為-0.41和-0.34,與治療96h臨床錶現積分降低值的相關繫數為-0.36;以上相關繫數均具有統計學意義(P<0.05).結論 血漿IL-10濃度與AECOPD治療效果呈正相關而IL-13濃度與治療效果呈負相關.
목적 탐토COPD급성가중기(AECOPD)환자혈장백개소(IL)-10、IL-13농도여림상치료효과지간적관계.방법 36례AECOPD주원치료환자피납입연구,용매련면역흡부시험검측환자입원시적혈장IL-10화IL-13농도,대환자적림상표현진행양화평분,근거환자입원시、치료48h、치료96 h적림상표현적분결합폐통기공능지표대치료효과진행평개,분석IL-10、IL-13농도여치료효과지간적관계.결과 IL-10농도여치료48 h림상표현적분강저치화폐통기공능개선치적상관계수분별위0.85화0.48,여치료96 h림상표현적분강저치화폐통기공능개선치적상관계수분별위0.64화0.52;IL-13농도여치료48 h림상표현적분강저치화폐통기공능개선치적상관계수분별위-0.41화-0.34,여치료96h림상표현적분강저치적상관계수위-0.36;이상상관계수균구유통계학의의(P<0.05).결론 혈장IL-10농도여AECOPD치료효과정정상관이IL-13농도여치료효과정부상관.
Objective To investigate the relationship among the concentration of plasma interleukin (IL)-10 and plasma IL-13 and the clinical therapeutic effect in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods Thirty-six AECOPD inpatients were enrolled in this study.Blood samples of the subjects were collected as soon as hospitalization, and plasma IL-10 and IL-13concentrations were analyzed by enzyme-linked immunosorbent assay.The clinical manifestations of subjects were quantified by a special designed score standard, and were evaluated at the time points of hospitalization, 48 hours treatment and 96 hours treatment.The therapeutic effect was evaluated by clinical manifestations score combined with pulmonary ventilation functional parameter.Eventually, the correlation among the concentration of IL-10 concentration and IL-13 and the clinical therapeutic effect were analyzed.Results The correlation coefficients between clinical manifestations score decrease and pulmonary ventilation function improvement with plasma IL-10 concentration after 48 hours treatment were 0.85 and 0.48 respectively,then, 0.64 and 0.52 after 96 hours treatment.The correlation coefficients between clinical manifestations score decrease and pulmonary ventilation function improvement with plasma IL-13 concentration after 48hours treatment were -0.41 and -0.34, after 96 hours treatment , correlation coefficients between clinical manifestations score decrease with plasma IL-13 concentration was -0.36.All of the above correlation coefficients were statistically significant.Conclusion Plasma IL-10 concentration was positively, whereas, IL-13 concentration was negatively correlated with the therapeutic effect in AECOPD patients.